Filing Details
- Accession Number:
- 0001110803-13-000368
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-11-05 19:48:33
- Reporting Period:
- 2013-11-01
- Filing Date:
- 2013-11-05
- Accepted Time:
- 2013-11-05 19:48:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1231845 | Karin Eastham | 5200 Illumina Way San Diego CA 92122 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-11-01 | 10,000 | $17.58 | 18,284 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-11-01 | 800 | $93.89 | 17,484 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-11-01 | 6,855 | $94.92 | 10,629 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-11-01 | 2,345 | $95.58 | 8,284 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-11-01 | 10,000 | $0.00 | 10,000 | $17.58 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 6,000 | 2008-06-07 | 2017-06-07 | No | 4 | M | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 800 shares sold ranging from $93.415 to $94.35 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 6,855 shares sold ranging from $94.45 to $95.44 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 2,345 shares sold ranging from $95.45 to $95.93 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
Billionaire Hedge Funds
